,X,FilingDate,TradeDate,Ticker,InsiderName,Title,TradeType,Price,Qty,Owned,delta_Own,Value,1d,1w,1m,6m,ticker
0,D,2021-08-12 16:20:57,2021-08-10,FULC,Moxham Christopher,Chief Scientific Officer,M - OptEx,7.84,51785,31071,-250%,405994.0,,,,,FULC
1,D,2021-08-12 16:20:57,2021-08-10,FULC,Moxham Christopher,Chief Scientific Officer,S - Sale+OE,17.6,-51785,31071,-63%,-911416.0,,,,,FULC
2,DM,2021-08-12 16:20:48,2021-08-10,FULC,Stuart Bryan,See Remarks,M - OptEx,7.84,60000,0,-100%,470400.0,,,,,FULC
3,DM,2021-08-12 16:20:48,2021-08-10,FULC,Stuart Bryan,See Remarks,S - Sale+OE,20.42,-60000,0,-100%,-1225000.0,,,,,FULC
4,,2021-06-29 16:16:32,2021-06-28,FULC,Morabito Christopher,Chief Medical Officer,P - Purchase,9.16,1100,1100,New,10076.0,,,,,FULC
5,,2021-06-29 16:16:09,2021-06-28,FULC,Oltmans Curtis Gale,"SVP, GC",P - Purchase,9.01,1088,1088,New,9803.0,,,,,FULC
6,,2021-06-29 16:15:58,2021-06-28,FULC,Thomson Peter G.,"VP Finance, Accounting",P - Purchase,9.0,2300,2300,New,20700.0,,,,,FULC
7,,2021-06-29 16:15:13,2021-06-28,FULC,Geraghty James A,Dir,P - Purchase,9.16,10000,90714,+12%,91600.0,,,,,FULC
8,M,2021-03-17 16:30:18,2021-03-15,FULC,Gould Robert J,See Remarks,S - Sale,12.16,-10000,506630,-2%,-121578.0,,,,,FULC
9,D,2021-02-24 16:30:24,2021-02-22,FULC,Thomson Peter G.,"VP Finance, Accounting",M - OptEx,7.84,5000,15212,+49%,39200.0,,,,,FULC
10,D,2021-02-24 16:30:24,2021-02-22,FULC,Thomson Peter G.,"VP Finance, Accounting",S - Sale+OE,14.72,-5000,15212,-25%,-73582.0,,,,,FULC
11,,2021-02-18 16:30:21,2021-02-16,FULC,Gould Robert J,See Remarks,S - Sale,14.27,-8215,516630,-2%,-117197.0,,,,,FULC
12,,2021-01-25 16:30:09,2021-01-21,FULC,Thomson Peter G.,"VP Finance, Accounting",S - Sale,14.0,-6607,15212,-30%,-92498.0,,,,,FULC
13,,2021-01-22 16:30:10,2021-01-20,FULC,Gould Robert J,See Remarks,S - Sale,12.08,-10000,524845,-2%,-120826.0,,,,,FULC
14,D,2020-09-14 16:19:08,2020-09-14,FULC,Wallace Owen B.,Chief Scientific Officer,M - OptEx,7.84,6350,133438,+5%,49784.0,,,,,FULC
15,D,2020-07-09 16:18:32,2020-07-08,FULC,Wallace Owen B.,Chief Scientific Officer,M - OptEx,7.84,2951,127088,+2%,23136.0,,,,,FULC
16,D,2020-07-09 16:18:32,2020-07-08,FULC,Wallace Owen B.,Chief Scientific Officer,S - Sale+OE,20.0,-2951,127088,-2%,-59020.0,,,,,FULC
17,,2020-07-09 16:15:54,2020-07-08,FULC,Gould Robert J,See Remarks,S - Sale,20.0,-2500,534845,0%,-50000.0,,,,,FULC
18,,2020-07-02 16:19:30,2020-07-01,FULC,Cadavid Diego,SVP Clinical Development,S - Sale,18.3,-1071,65714,-2%,-19599.0,,,,,FULC
19,D,2020-07-01 16:39:22,2020-06-30,FULC,Wallace Owen B.,Chief Scientific Officer,M - OptEx,7.84,141,127088,0%,1105.0,,,,,FULC
20,D,2020-07-01 16:39:22,2020-06-30,FULC,Wallace Owen B.,Chief Scientific Officer,S - Sale+OE,20.0,-141,127088,0%,-2820.0,,,,,FULC
21,D,2020-06-26 16:17:31,2020-06-25,FULC,Cadavid Diego,SVP Clinical Development,M - OptEx,4.83,1459,66785,+2%,7047.0,,,,,FULC
22,D,2020-06-26 16:17:31,2020-06-25,FULC,Cadavid Diego,SVP Clinical Development,S - Sale+OE,22.0,-1459,66785,-2%,-32098.0,,,,,FULC
23,,2020-06-26 16:15:21,2020-06-25,FULC,Gould Robert J,See Remarks,S - Sale,20.8,-2500,537345,0%,-51992.0,,,,,FULC
24,D,2020-06-12 17:10:56,2020-06-10,FULC,Cadavid Diego,SVP Clinical Development,M - OptEx,4.83,401,66785,+1%,1937.0,,,,,FULC
25,D,2020-06-12 17:10:56,2020-06-10,FULC,Cadavid Diego,SVP Clinical Development,S - Sale+OE,22.0,-401,66785,-1%,-8822.0,,,,,FULC
26,,2020-06-10 16:15:33,2020-06-09,FULC,Gould Robert J,See Remarks,S - Sale,20.0,-156,539845,0%,-3120.0,,,,,FULC
27,,2020-06-09 16:16:01,2020-06-05,FULC,Gould Robert J,See Remarks,S - Sale,20.17,-3433,540001,-1%,-69251.0,,,,,FULC
28,DM,2020-06-08 16:17:07,2020-06-04,FULC,Cadavid Diego,SVP Clinical Development,M - OptEx,4.83,677,66785,+1%,3270.0,,,,,FULC
29,DM,2020-06-08 16:17:07,2020-06-04,FULC,Cadavid Diego,SVP Clinical Development,S - Sale+OE,20.14,-677,66785,-1%,-13632.0,,,,,FULC
30,M,2020-06-05 16:26:55,2020-06-03,FULC,Gould Robert J,See Remarks,S - Sale,20.09,-2800,543434,-1%,-56250.0,,,,,FULC
31,DM,2020-06-04 16:16:09,2020-06-02,FULC,Cadavid Diego,SVP Clinical Development,M - OptEx,4.83,383,66785,+1%,1850.0,,,,,FULC
32,DM,2020-06-04 16:16:09,2020-06-02,FULC,Cadavid Diego,SVP Clinical Development,S - Sale+OE,20.16,-383,66785,-1%,-7720.0,,,,,FULC
33,M,2020-06-03 16:17:17,2020-06-01,FULC,Gould Robert J,See Remarks,S - Sale,20.0,-2802,546234,-1%,-56040.0,,,,,FULC
34,DM,2020-06-01 16:16:30,2020-05-28,FULC,Cadavid Diego,SVP Clinical Development,M - OptEx,4.83,800,66785,+1%,3864.0,,,,,FULC
35,DM,2020-06-01 16:16:30,2020-05-28,FULC,Cadavid Diego,SVP Clinical Development,S - Sale+OE,20.01,-800,66785,-1%,-16007.0,,,,,FULC
36,M,2020-06-01 16:15:47,2020-05-28,FULC,Gould Robert J,See Remarks,S - Sale,20.04,-3309,549036,-1%,-66302.0,,,,,FULC
37,D,2020-06-01 16:15:25,2020-05-28,FULC,Wallace Owen B.,Chief Scientific Officer,M - OptEx,7.84,2232,127088,+2%,17499.0,,,,,FULC
38,D,2020-06-01 16:15:25,2020-05-28,FULC,Wallace Owen B.,Chief Scientific Officer,S - Sale+OE,20.0,-2232,127088,-2%,-44640.0,,,,,FULC
39,D,2020-05-29 16:15:26,2020-05-27,FULC,Wallace Owen B.,Chief Scientific Officer,M - OptEx,7.84,448,127088,0%,3512.0,,,,,FULC
40,D,2020-05-29 16:15:26,2020-05-27,FULC,Wallace Owen B.,Chief Scientific Officer,S - Sale+OE,20.0,-448,127088,0%,-8960.0,,,,,FULC
41,D,2020-05-28 16:16:49,2020-05-26,FULC,Wallace Owen B.,Chief Scientific Officer,M - OptEx,7.84,412,127088,0%,3230.0,,,,,FULC
42,D,2020-05-28 16:16:49,2020-05-26,FULC,Wallace Owen B.,Chief Scientific Officer,S - Sale+OE,20.0,-412,127088,0%,-8240.0,,,,,FULC
43,,2020-05-28 16:15:57,2020-05-26,FULC,Gould Robert J,See Remarks,S - Sale,20.0,-2500,552345,0%,-50000.0,,,,,FULC
44,D,2020-05-12 16:15:47,2020-05-12,FULC,Cadavid Diego,SVP Clinical Development,M - OptEx,4.83,1860,66785,+3%,8984.0,,,,,FULC
45,D,2020-05-12 16:15:47,2020-05-12,FULC,Cadavid Diego,SVP Clinical Development,S - Sale+OE,18.0,-1860,66785,-3%,-33480.0,,,,,FULC
46,,2020-05-12 16:15:21,2020-05-11,FULC,Thomson Peter G.,"VP Finance, Accounting",S - Sale,16.0,-7500,21071,-26%,-120000.0,,,,,FULC
47,,2020-03-02 18:42:26,2020-03-02,FULC,Cadavid Diego,SVP Clinical Development,S - Sale,17.38,-2143,66785,-3%,-37255.0,,,,,FULC
48,,2020-02-26 19:52:44,2020-02-24,FULC,Thomson Peter G.,"VP Finance, Accounting",S - Sale,16.83,-5000,28571,-15%,-84153.0,,,,,FULC
49,,2020-02-20 16:24:02,2020-02-19,FULC,Gould Robert J,See Remarks,S - Sale,20.0,-2500,554845,0%,-50000.0,,,,,FULC
50,D,2020-02-20 16:23:58,2020-02-19,FULC,Wallace Owen B.,Chief Scientific Officer,M - OptEx,7.84,6088,127088,+5%,47730.0,,,,,FULC
51,D,2020-02-20 16:23:58,2020-02-19,FULC,Wallace Owen B.,Chief Scientific Officer,S - Sale+OE,20.0,-6088,127088,-5%,-121760.0,,,,,FULC
52,,2020-02-05 16:31:44,2020-02-03,FULC,Cadavid Diego,SVP Clinical Development,S - Sale,17.33,-2143,68928,-3%,-37142.0,,,,,FULC
53,D,2020-01-27 16:28:26,2020-01-23,FULC,Thomson Peter G.,"VP Finance, Accounting",S - Sale+OE,17.22,-5000,33571,-13%,-86102.0,,,,,FULC
54,D,2019-07-24 16:01:08,2019-07-22,FULC,Glaxosmithkline Plc,10%,C - Converted deriv,0.0,1785714,1785714,-50%,0.0,,,,,FULC
55,D,2019-07-23 11:39:19,2019-07-22,FULC,Sanofi,10%,C - Converted deriv,0.0,464285,558035,-45%,0.0,,,,,FULC
56,D,2019-07-23 11:39:19,2019-07-22,FULC,Sanofi,10%,P - Purchase,16.0,93750,558035,+20%,1500000.0,,,,,FULC
57,D,2019-07-22 16:38:31,2019-07-22,FULC,"Third Rock Ventures Iv, L.P.",10%,C - Converted deriv,0.0,2261904,2343154,-49%,0.0,,,,,FULC
58,D,2019-07-22 16:38:31,2019-07-22,FULC,"Third Rock Ventures Iv, L.P.",10%,P - Purchase,16.0,81250,2343154,+4%,1300000.0,,,,,FULC
59,D,2019-07-22 16:34:59,2019-07-22,FULC,"Third Rock Ventures Iii, L.P.",10%,C - Converted deriv,0.0,5595238,5962202,-48%,0.0,,,,,FULC
60,D,2019-07-22 16:34:59,2019-07-22,FULC,"Third Rock Ventures Iii, L.P.",10%,P - Purchase,16.0,81250,5962202,+1%,1300000.0,,,,,FULC
61,D,2019-07-22 16:32:02,2019-07-22,FULC,"6 Dimensions Capital, L.P.",10%,C - Converted deriv,0.0,441071,559821,-44%,0.0,,,,,FULC
62,D,2019-07-22 16:32:02,2019-07-22,FULC,"6 Dimensions Capital, L.P.",10%,P - Purchase,16.0,118750,559821,+27%,1900000.0,,,,,FULC
63,D,2019-07-22 16:31:32,2019-07-22,FULC,"Casdin Capital, LLC",10%,C - Converted deriv,0.0,464285,604285,-43%,0.0,,,,,FULC
64,D,2019-07-22 16:31:32,2019-07-22,FULC,"Casdin Capital, LLC",10%,P - Purchase,15.84,140000,604285,+30%,2217495.0,,,,,FULC
65,D,2019-07-22 16:31:01,2019-07-22,FULC,Levin Mark J,"Dir, 10%",C - Converted deriv,0.0,5595238,5962202,-48%,0.0,,,,,FULC
66,D,2019-07-22 16:31:01,2019-07-22,FULC,Levin Mark J,"Dir, 10%",P - Purchase,16.0,81250,5962202,+1%,1300000.0,,,,,FULC
67,D,2019-07-22 16:30:46,2019-07-22,FULC,"Section 32 Fund 2, LP",10%,C - Converted deriv,0.0,464285,464285,-50%,0.0,,,,,FULC
